US5174993A
(en)
*
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US5833975A
(en)
*
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
FR2596414B1
(fr)
*
|
1986-03-28 |
1989-10-06 |
Pasteur Institut |
Hybridomes obtenus a partir de lymphocytes d'animaux transgeniques portant un gene exprimant une proteine donnee et procede de preparation d'une telle proteine a partir de tels hybridomes
|
ATE141646T1
(de)
*
|
1986-04-09 |
1996-09-15 |
Genzyme Corp |
Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern
|
ES2090006T3
(es)
*
|
1986-05-20 |
1996-10-16 |
Gen Hospital Corp |
Evaluacion de la expresion de preproinsulina, proinsulina o insulina.
|
US5322775A
(en)
*
|
1986-06-30 |
1994-06-21 |
Pharmaceutical Proteins Ltd. |
Peptide production
|
US5470560A
(en)
*
|
1987-01-20 |
1995-11-28 |
Genentech, Inc. |
Method for evaluating immunogenicity
|
EP0279582A3
(en)
*
|
1987-02-17 |
1989-10-18 |
Pharming B.V. |
Dna sequences to target proteins to the mammary gland for efficient secretion
|
DE3854823T2
(de)
*
|
1987-05-01 |
1996-05-23 |
Stratagene Inc |
Mutagenesetest durch Verwendung von nicht menschlichen Lebewesen, die Test-DNS-Sequenzen enthalten
|
US5851819A
(en)
*
|
1987-06-16 |
1998-12-22 |
National Institutes Of Health |
Vectors carrying MDR1 cDNA which confer multidrug resistance on transduced cells
|
US5075229A
(en)
*
|
1987-06-16 |
1991-12-24 |
Ohio University Edison Animal Biotechnology Center |
Dietary and hormonal regulation of expression of exogenous genes in transgenic animals under control of the promoter of the gene for phosphoenolpyruvate carboxykinase
|
US5928637A
(en)
*
|
1987-06-16 |
1999-07-27 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods of inducing multidrug resistance using human MDR1 cDNA
|
JPH03500482A
(ja)
*
|
1987-06-16 |
1991-02-07 |
オハイオ ユニバーシティ |
ホスホエノールピルベート カルボキシキナーゼに係る遺伝子のプロモーターの制御下における、遺伝子導入動物の外来遺伝子の発現の食餌およびホルモンによる調節
|
FR2637613B1
(fr)
*
|
1987-06-19 |
1991-09-27 |
Transgene Sa |
Procede de preparation de lignees cellulaires stables pour la production de proteines determinees, a partir d'animaux transgeniques; lignees cellulaires tumorales et proteines obtenues
|
US4873316A
(en)
*
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
US5851991A
(en)
*
|
1987-08-31 |
1998-12-22 |
The Regents Of The University Of California |
Therapeutic use of the retinoblastoma susceptibility gene product
|
US7105156B1
(en)
|
1987-09-17 |
2006-09-12 |
The Regents Of The University Of California |
Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
|
AU2900389A
(en)
*
|
1987-12-15 |
1989-07-19 |
Trustees Of Princeton University, The |
Transgenic testing systems for mutagens and carcinogens
|
US20030032178A1
(en)
*
|
1988-08-04 |
2003-02-13 |
Williams Robert Lindsay |
In vitro propagation of embryonic stem cells
|
US5221778A
(en)
*
|
1988-08-24 |
1993-06-22 |
Yale University |
Multiplex gene regulation
|
GB2223755A
(en)
*
|
1988-09-21 |
1990-04-18 |
Cambridge Animal Biotech |
Tissue modification
|
US6436701B1
(en)
|
1988-09-21 |
2002-08-20 |
Babraham Institute |
Derivation of pluripotential embryonic cell lines from ungulate species
|
EP0451157A4
(en)
*
|
1988-10-21 |
1992-01-02 |
Us Health |
Transgenic animals for testing multidrug resistance
|
ATE161039T1
(de)
*
|
1988-10-31 |
1997-12-15 |
Univ California |
Erzeugnisse und verfahren zur regelung der suppression von neoplastischen phenotypen
|
US5880260A
(en)
*
|
1988-11-18 |
1999-03-09 |
Oregon Health Sciences University |
Dopamine receptors and genes
|
EP0439553A1
(en)
*
|
1988-11-30 |
1991-08-07 |
The Upjohn Company |
Transgenic mice for the analysis of hair growth
|
CA2006011A1
(en)
*
|
1988-12-21 |
1990-06-21 |
Cecilia Lo |
Transgenic organisms and cells and methods of producing transgenic organisms and cells
|
US5215904A
(en)
*
|
1989-01-27 |
1993-06-01 |
Wisconsin Alumni Research Foundation |
Method for producing a recombinant mammal in vivo
|
US5175383A
(en)
*
|
1989-02-17 |
1992-12-29 |
President And Fellows Of Harvard College |
Animal model for benign prostatic disease
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
DK198089D0
(da)
*
|
1989-04-24 |
1989-04-24 |
Danske Spritfabrikker |
Dna-materialer og anvendelse deraf
|
US5498832A
(en)
*
|
1989-04-24 |
1996-03-12 |
A/S De Danske Spritfabrikker |
Potato α-amylase genes
|
WO1990015869A1
(en)
*
|
1989-06-19 |
1990-12-27 |
Embryogen Corporation |
Transgenic skin-testing systems
|
US6218596B1
(en)
*
|
1989-06-30 |
2001-04-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Enhancement of musculature in non-human mammals expressing c-ski
|
US5174986A
(en)
*
|
1989-07-05 |
1992-12-29 |
Genpharm International, Inc. |
Method for determining oncogenic potential of a chemical compound
|
EP0433437A4
(en)
*
|
1989-07-05 |
1991-08-14 |
Genpharm International |
Method for determining oncogenic potential of a chemical compound
|
US5665543A
(en)
*
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
US5776502A
(en)
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
US6203976B1
(en)
|
1989-07-18 |
2001-03-20 |
Osi Pharmaceuticals, Inc. |
Methods of preparing compositions comprising chemicals capable of transcriptional modulation
|
US5580722A
(en)
*
|
1989-07-18 |
1996-12-03 |
Oncogene Science, Inc. |
Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
|
DE69034061D1
(de)
*
|
1989-07-18 |
2003-05-28 |
Osi Pharm Inc |
Methode der veränderung der expression von genen bei der transkription und zum nachweis von chemischen substanzen, die wie modulatoren der genexpression wirken
|
US6689610B1
(en)
|
1989-08-22 |
2004-02-10 |
University Of Utah Research Foundation |
Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
|
US5464764A
(en)
*
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
CA2066614A1
(en)
*
|
1989-09-15 |
1991-03-16 |
Cha-Mer Wei |
Transgenic animal model for viral infections
|
AU6882791A
(en)
*
|
1989-11-22 |
1991-06-13 |
Children's Hospital Of Los Angeles |
Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US5262529A
(en)
*
|
1990-01-24 |
1993-11-16 |
President And Fellows Of Harvard College |
Diagnosis of hereditary retinal degenerative diseases
|
US5225546A
(en)
*
|
1990-01-24 |
1993-07-06 |
President And Fellows Of Harvard College |
Diagnosis of hereditary retinal degenerative disease
|
US5498521A
(en)
*
|
1990-01-24 |
1996-03-12 |
President And Fellows Of Harvard College |
Diagnosis of hereditary retinal degenerative diseases
|
GB9003791D0
(en)
*
|
1990-02-20 |
1990-04-18 |
Ludwig Inst Cancer Res |
Transgenic animals,cell lines therefrom,and their use
|
WO1991013979A1
(en)
*
|
1990-03-05 |
1991-09-19 |
President And Fellows Of Harvard College |
Transgenic mouse overexpressing il-4 and method of use
|
WO1991015116A1
(en)
*
|
1990-03-30 |
1991-10-17 |
Amrad Corporation Limited |
Doubly transgenic animals
|
CA2079792A1
(en)
*
|
1990-04-05 |
1991-10-06 |
Joseph A. Sorge |
Mutagenesis testing using transgenic non-human animals carrying test dna sequences
|
US5244656A
(en)
*
|
1990-05-04 |
1993-09-14 |
Wisconsin Alumni Research Foundation |
Antigen specific plasmacytomas and antibodies derived therefrom
|
US5614396A
(en)
*
|
1990-06-14 |
1997-03-25 |
Baylor College Of Medicine |
Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
|
GB9017020D0
(en)
*
|
1990-08-02 |
1990-09-19 |
Cancer Res Campaign Tech |
Nucleic acid sequences having unusual properties and uses thereof
|
WO1992006104A1
(en)
*
|
1990-09-28 |
1992-04-16 |
The Dana-Farber Cancer Institute |
Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism
|
US5489742A
(en)
*
|
1990-10-23 |
1996-02-06 |
Board Of Regents, The University Of Texas System |
Transgenic rats and animal models of inflammatory disease
|
JPH06502078A
(ja)
*
|
1990-12-03 |
1994-03-10 |
アメリカ合衆国 |
動物における筋肉組織の増大
|
WO1992011874A1
(en)
*
|
1991-01-04 |
1992-07-23 |
Baylor College Of Medicine |
Tumor susceptible non-human animals
|
US5569824A
(en)
*
|
1991-01-04 |
1996-10-29 |
Baylor College Of Medicine |
Transgenic mice containing a disrupted p53 gene
|
WO1992013091A1
(en)
*
|
1991-01-18 |
1992-08-06 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes
|
US5866759A
(en)
*
|
1991-02-20 |
1999-02-02 |
Ludwig Institute For Cancer Research |
Transgenic mice expressing TSSV40 large T antigen
|
US7150974B1
(en)
|
1991-04-05 |
2006-12-19 |
The General Hospital Corporation |
Parathyroid hormone receptor binding method
|
ATE287898T1
(de)
*
|
1991-04-05 |
2005-02-15 |
Gen Hospital Corp |
Parathyroid-hormon-rezeptor und seine kodierende dna
|
US7132260B2
(en)
*
|
1991-04-05 |
2006-11-07 |
The General Hospital Corporation |
DNA encoding parathyroid hormone receptor
|
US5261686A
(en)
*
|
1992-04-06 |
1993-11-16 |
Buckler Clive E |
Semi-recumbent
|
US6268211B1
(en)
|
1991-08-20 |
2001-07-31 |
L'institut De Recherches Cliniques De Montreal |
Non-infectious HIV transgene
|
WO1992020790A1
(en)
*
|
1991-05-15 |
1992-11-26 |
L'institut De Recherches Cliniques De Montreal |
Transgenic non-human animal carrying a non-infectious hiv genome
|
WO1992022333A1
(en)
*
|
1991-06-12 |
1992-12-23 |
Thomas Jefferson University |
Transgenic mice expressing human collagen gene
|
DE4126968A1
(de)
*
|
1991-08-14 |
1993-02-18 |
Detlev Prof Dr Med Ganten |
Transgene ratten, die in ihrem genom mindestens ein menschliches gen enthalten, das an der blutdruckregulation beteiligt ist
|
AU2765992A
(en)
|
1991-10-03 |
1993-05-03 |
Indiana University Foundation |
Method for screening for alzheimer's disease
|
AU2861892A
(en)
*
|
1991-10-04 |
1993-05-03 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Astrocyte-specific transcription of human genes
|
US6683232B1
(en)
*
|
1991-10-10 |
2004-01-27 |
Rhone-Poulenc Agrochimie |
Production of γ linolenic acid by a Δ6-desaturase
|
US20070130654A1
(en)
*
|
1991-10-10 |
2007-06-07 |
Thomas Terry L |
Production of gamma linolenic acid by a delta6-desaturase
|
PH31293A
(en)
*
|
1991-10-10 |
1998-07-06 |
Rhone Poulenc Agrochimie |
Production of y-linolenic acid by a delta6-desaturage.
|
US20090077692A1
(en)
*
|
1991-10-10 |
2009-03-19 |
Thomas Terry L |
Production of gamma linolenic acid by a delta6-desaturase
|
US5614393A
(en)
*
|
1991-10-10 |
1997-03-25 |
Rhone-Poulenc Agrochimie |
Production of γ-linolenic acid by a Δ6-desaturase
|
ES2237747T3
(es)
*
|
1991-11-14 |
2005-08-01 |
Prionics Ag |
Animales transgenicos no humanos que carecen de proteinas prionicas.
|
DK8892D0
(da)
|
1992-01-23 |
1992-01-23 |
Symbicom Ab |
Humant proteingen
|
US5859307A
(en)
*
|
1992-02-04 |
1999-01-12 |
Massachusetts Institute Of Technology |
Mutant RAG-1 deficient animals having no mature B and T lymphocytes
|
WO1993015769A1
(en)
*
|
1992-02-14 |
1993-08-19 |
Stratagene |
Mutagenesis testing using transgenic non-human animals carrying test dna sequences
|
AU672409B2
(en)
*
|
1992-04-30 |
1996-10-03 |
Baylor College Of Medicine |
Development of a vector to target gene expression to the epidermis of transgenic animals
|
US5914265A
(en)
*
|
1992-04-30 |
1999-06-22 |
Baylor College Of Medicine |
Keratin K1 expression vectors and methods of use
|
WO1998018925A2
(en)
*
|
1996-10-29 |
1998-05-07 |
Valentis, Inc. |
Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
|
DE69334150T2
(de)
*
|
1992-05-14 |
2008-03-13 |
Baylor College Of Medicine, Houston |
Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
|
US6416998B1
(en)
|
1992-09-02 |
2002-07-09 |
Baylor College Of Medicine |
Plasmid encoding a modified steroid hormone
|
CA2135313A1
(en)
*
|
1992-06-18 |
1994-01-06 |
Theodore Choi |
Methods for producing transgenic non-human animals harboring a yeast artificial chromosome
|
US6610493B1
(en)
*
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
US5602307A
(en)
*
|
1992-08-12 |
1997-02-11 |
Baylor College Of Medicine |
Non-human animal having predefined allele of a cellular adhesion gene
|
US5714146A
(en)
*
|
1992-08-26 |
1998-02-03 |
Board Of Regents Of The University Of Washington |
IL-4 bone therapy
|
US6264915B1
(en)
|
1992-09-13 |
2001-07-24 |
The President And Fellows Of Harvard College |
Process for detecting potential carcinogens
|
US5833945A
(en)
*
|
1992-09-30 |
1998-11-10 |
Sakuma; Moto |
Animal model of pathological behavior
|
CA2110946A1
(en)
*
|
1992-12-09 |
1994-06-10 |
Elazar Rabbani |
Induction of immunocompatibility by nucleic acid
|
US20020127548A1
(en)
*
|
1992-12-11 |
2002-09-12 |
Christine Siedman |
Methods for detecting mutations associated with hypertrophic cardiomyopathy
|
US5912121A
(en)
*
|
1992-12-11 |
1999-06-15 |
Bringham And Women's Hospital |
Methods for detecting mutations associated with hypertrophic cardiomyopathy
|
US5650278A
(en)
*
|
1992-12-22 |
1997-07-22 |
Children's Hospital Of Philadelphia |
Compositions and diagnostic kits for identifying alveolar rhabdomyosarcoma
|
US5981175A
(en)
*
|
1993-01-07 |
1999-11-09 |
Genpharm Internation, Inc. |
Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome
|
US5489743A
(en)
*
|
1993-01-19 |
1996-02-06 |
Amgen Inc. |
Transgenic animal models for thrombocytopenia
|
CA2159195A1
(en)
*
|
1993-03-26 |
1994-10-13 |
Darwin J. Prockop |
Use of a col 1a1 mini-gene construct to inhibit collagen synthesis
|
US6340674B1
(en)
|
1993-03-26 |
2002-01-22 |
Thomas Jefferson University |
Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
|
WO1994023760A1
(en)
*
|
1993-04-14 |
1994-10-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Transgenic animal model for autoimmune diseases
|
US5523226A
(en)
*
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
US6310034B1
(en)
|
1993-05-21 |
2001-10-30 |
Ut-Battelle, Llc |
Agouti polypeptide compositions
|
US5843652A
(en)
*
|
1993-05-21 |
1998-12-01 |
Lockheed Martin Energy Systems, Inc. |
Isolation and characterization of Agouti: a diabetes/obesity related gene
|
US5547868A
(en)
*
|
1993-06-09 |
1996-08-20 |
Regents Of The University Of California |
Cholesterol disposal fusion enzymes
|
US5731411A
(en)
*
|
1993-07-12 |
1998-03-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Promotion of homologous DNA pairing by RecA-derived peptides
|
WO1995003402A1
(en)
*
|
1993-07-22 |
1995-02-02 |
Merck & Co., Inc. |
EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL
|
US5650550A
(en)
*
|
1993-10-01 |
1997-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mutant mice having a deficit of functional estrogen receptors
|
US5602309A
(en)
*
|
1993-10-04 |
1997-02-11 |
University Of Kentucky Research Foundation |
Transgenic mice which overexpress nerve growth factor
|
DK0730643T3
(da)
|
1993-10-27 |
2001-05-14 |
Elan Pharm Inc |
Transgene dyr, som huser APP-allel med svensk mutation
|
AU8102694A
(en)
*
|
1993-11-17 |
1995-06-06 |
Id Biomedical Corporation |
Cycling probe cleavage detection of nucleic acid sequences
|
US5466465A
(en)
*
|
1993-12-30 |
1995-11-14 |
Harrogate Holdings, Limited |
Transdermal drug delivery system
|
US5932780A
(en)
*
|
1994-02-28 |
1999-08-03 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Transgenic non-human animal assay system for anti-cholinesterase substances
|
US6025183A
(en)
*
|
1994-02-28 |
2000-02-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Transgenic animal assay system for anti-cholinesterase substances
|
US5858774A
(en)
*
|
1994-05-12 |
1999-01-12 |
The Research Foundation Of State University Of New York |
Antisense DNA constructs for expression of hybrid MRNAs driven by inducible, tissue-specific promoters
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5601820A
(en)
*
|
1994-07-07 |
1997-02-11 |
Children's Hospital Of Philadelphia |
Compositions and methods of making and using human full length TRK-B
|
US5714170A
(en)
|
1994-11-16 |
1998-02-03 |
Thomas Jefferson University |
Method of inducing resistance to tumor growth
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5859308A
(en)
*
|
1994-12-29 |
1999-01-12 |
University Of Medicine And Denistry Of New Jersey |
Transgenic animals and related aspects
|
CN1183802A
(zh)
|
1994-12-30 |
1998-06-03 |
行星生物技术有限公司 |
在植物中生产含有保护性蛋白质的免疫球蛋白的方法和应用
|
US6046037A
(en)
*
|
1994-12-30 |
2000-04-04 |
Hiatt; Andrew C. |
Method for producing immunoglobulins containing protection proteins in plants and their use
|
US6808709B1
(en)
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
US5702948A
(en)
*
|
1995-02-02 |
1997-12-30 |
The Trustees Of The University Of Pennsylvania |
Saccular collagen and compositions and methods for making and using the same
|
US5675063A
(en)
*
|
1995-02-28 |
1997-10-07 |
Loyola University Of Chicago |
Immortalized rabbit hybridoma fusion partner
|
US5814300A
(en)
*
|
1995-03-03 |
1998-09-29 |
Cephalon, Inc. |
Gene-targeted non-human mammals deficient in the SOD-1 gene
|
US5674748A
(en)
*
|
1995-03-14 |
1997-10-07 |
Thomas Jefferson University |
Human cyclin-dependent kinase-like proteins and methods of using the same
|
US5714378A
(en)
*
|
1995-03-31 |
1998-02-03 |
The United States Of America As Represented By The Secretary Of The Navy |
Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5672500A
(en)
*
|
1995-05-18 |
1997-09-30 |
Thomas Jefferson University |
Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
|
US6187991B1
(en)
|
1995-05-23 |
2001-02-13 |
Pfizer Inc |
Transgenic animal models for type II diabetes mellitus
|
US5876949A
(en)
*
|
1995-05-31 |
1999-03-02 |
The Trustees Of The University Of Pennsylvania |
Antibodies specific for fragile X related proteins and method of using the same
|
US6717031B2
(en)
|
1995-06-07 |
2004-04-06 |
Kate Dora Games |
Method for selecting a transgenic mouse model of alzheimer's disease
|
US5942386A
(en)
*
|
1995-06-07 |
1999-08-24 |
Thomas Jefferson University |
Anti-fungal agents and methods of identifying and using the same
|
US5691187A
(en)
*
|
1995-06-07 |
1997-11-25 |
Thomas Jefferson University |
Anti-fungal agents and methods of identifying and using the same
|
US5817783A
(en)
*
|
1995-06-22 |
1998-10-06 |
Thomas Jefferson University |
DR-nm23 and compositions, methods of making and methods of using the same
|
US6010694A
(en)
*
|
1995-07-27 |
2000-01-04 |
Thomas Jefferson University |
Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same
|
US5817290A
(en)
*
|
1995-07-28 |
1998-10-06 |
Beth Israel Deaconess Medical Center |
Method of and test kit for mutagenesis testing
|
US5912160A
(en)
*
|
1995-08-22 |
1999-06-15 |
Thomas Jefferson University |
Gab1, Grb2 binding protein, and compositions for making and methods of using the same
|
US6248555B1
(en)
|
1995-08-31 |
2001-06-19 |
The General Hospital Corporation |
Genetic alterations related to familial alzheimer's disease
|
KR19990044317A
(ko)
*
|
1995-09-01 |
1999-06-25 |
라미 핀클러 ; 하나넬 크바탄스키 |
아밀포스파타제2C - PP 2Cα-발현의 조작 및 검출
|
EP0876480A4
(en)
*
|
1995-10-20 |
1999-10-20 |
Ludwig Inst Cancer Res |
ANIMALS WITH TARGETED GENE DELETION
|
US5861498A
(en)
*
|
1995-11-01 |
1999-01-19 |
Thomas Jefferson University |
Nucleotides encoding immunophilin FKBP46 and fragments thereof
|
JP2000500654A
(ja)
*
|
1995-11-14 |
2000-01-25 |
トーマス・ジェファーソン・ユニバーシティ |
可溶性igf−1受容体による腫瘍成長に対する誘導耐性
|
US5859311A
(en)
*
|
1995-11-27 |
1999-01-12 |
University Of Kentucky Research Foundation |
Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use
|
US6046048A
(en)
*
|
1996-01-09 |
2000-04-04 |
Genetech, Inc. |
Apo-2 ligand
|
US20050089958A1
(en)
*
|
1996-01-09 |
2005-04-28 |
Genentech, Inc. |
Apo-2 ligand
|
US6998116B1
(en)
*
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
US6030945A
(en)
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US5907079A
(en)
*
|
1996-01-18 |
1999-05-25 |
Amgen Canada Inc. |
MSH2 disrupted mice develop lymphomas
|
US6060587A
(en)
*
|
1996-01-29 |
2000-05-09 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
|
US5834279A
(en)
*
|
1996-03-07 |
1998-11-10 |
Trustees Of The University Of Pennsylvania |
Methods of identifying compounds that inhibit DNA synthesis in mycobacterium tuberculosis and compositions, reagents and kits for performing the same
|
US6140309A
(en)
*
|
1996-03-12 |
2000-10-31 |
University Of South Florida |
Vasoactive effects and free radical generation by β-amyloid peptides
|
US6333447B1
(en)
|
1996-03-29 |
2001-12-25 |
The General Hospital Corporation |
Transgenic model of heart failure
|
JP2000507829A
(ja)
*
|
1996-04-01 |
2000-06-27 |
ジェネンテック インコーポレーテッド |
Apo―2liおよびapo―3アポトーシスポリペプチド
|
US20020165157A1
(en)
*
|
1996-04-01 |
2002-11-07 |
Genentech, Inc. |
Apo-2LI and Apo-3 polypeptides
|
US5965392A
(en)
|
1996-04-08 |
1999-10-12 |
Bayer Corporation |
Neuropeptide Y receptor Y5 and nucleic acid sequences
|
US5919901A
(en)
*
|
1996-04-08 |
1999-07-06 |
Bayer Corporation |
Neuropeptide Y receptor Y5 and nucleic acid sequences
|
US20020160970A1
(en)
*
|
1996-04-10 |
2002-10-31 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
*
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US20030033617A1
(en)
*
|
1996-04-10 |
2003-02-13 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
GB9607953D0
(en)
|
1996-04-17 |
1996-06-19 |
Univ Liverpool |
Transgenic rat
|
DE69723580T2
(de)
*
|
1996-05-03 |
2004-06-03 |
Thomas Jefferson University |
Impfstoff gegen metastasierenden kolorektalkrebs.
|
US5824838A
(en)
*
|
1996-05-09 |
1998-10-20 |
Cedars-Sinai Medical Center |
Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions
|
CA2259123C
(en)
|
1996-07-01 |
2003-10-21 |
Jim A. Wright |
Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
|
US6462176B1
(en)
*
|
1996-09-23 |
2002-10-08 |
Genentech, Inc. |
Apo-3 polypeptide
|
AU4503497A
(en)
|
1996-09-26 |
1998-04-17 |
Leinwand, Leslie A. |
Transgenic model for heart failure
|
US5990281A
(en)
*
|
1996-09-30 |
1999-11-23 |
Genentech, Inc. |
Vertebrate smoothened proteins
|
US5898094A
(en)
*
|
1996-10-21 |
1999-04-27 |
University Of South Florida |
Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes
|
US5858778A
(en)
*
|
1996-12-27 |
1999-01-12 |
Thomas Jefferson University |
SF caspase-1 and compositions for making and methods of using the same
|
JP2002503091A
(ja)
|
1997-03-26 |
2002-01-29 |
リプロジェン,インコーポレイテッド |
子宮内膜症マウスモデル
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
US20020102706A1
(en)
*
|
1997-06-18 |
2002-08-01 |
Genentech, Inc. |
Apo-2DcR
|
WO1999021999A2
(en)
|
1997-10-29 |
1999-05-06 |
Genentech, Inc. |
Wnt-1 inducible genes
|
DE69837085T3
(de)
|
1997-04-16 |
2012-01-12 |
Millennium Pharmaceuticals, Inc. |
Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
|
WO1998049311A2
(en)
|
1997-04-30 |
1998-11-05 |
De Novo Enzyme Corporation |
Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
|
EP0981618B2
(en)
*
|
1997-05-15 |
2011-08-24 |
Genentech, Inc. |
Anti-apo-2 antibody
|
US20100152426A1
(en)
*
|
1997-05-15 |
2010-06-17 |
Ashkenazi Avi J |
Apo-2 receptor fusion proteins
|
US6342369B1
(en)
*
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6037461A
(en)
*
|
1997-05-20 |
2000-03-14 |
Thomas Jefferson University |
FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
|
US6541036B1
(en)
|
1997-05-29 |
2003-04-01 |
Thomas Jefferson University |
Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)
|
US6426411B1
(en)
|
1997-05-30 |
2002-07-30 |
Dana-Farber Cancer Institute |
PGC-1, a novel brown fat pparγ coactivator
|
JP2001523977A
(ja)
|
1997-06-05 |
2001-11-27 |
ザ ユニバーシティ オブ テキサス システム ボード オブ リージェンツ |
Apaf−1、ced−4ヒト相同体、カスパーゼ−3の活性化因子
|
IL133122A0
(en)
*
|
1997-06-18 |
2001-03-19 |
Genentech Inc |
Apo-2dcr polypeptides
|
US6087166A
(en)
|
1997-07-03 |
2000-07-11 |
Basf Aktiengesellschaft |
Transcriptional activators with graded transactivation potential
|
DE69841139D1
(de)
|
1997-07-14 |
2009-10-22 |
Univ Liege |
Mutationen im myostatingen steigern muskelmasse in säugetieren
|
US20070067859A1
(en)
*
|
1997-07-14 |
2007-03-22 |
Michel Georges |
Double-muscling in mammals
|
US6103466A
(en)
*
|
1997-07-14 |
2000-08-15 |
University Of Liege |
Double-muscling in mammals
|
US6391547B1
(en)
*
|
1997-09-09 |
2002-05-21 |
Center For The Application Of Molecular Biology To International Agriculture |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US7087420B1
(en)
|
1997-07-17 |
2006-08-08 |
Cambia |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6498285B1
(en)
|
1997-08-06 |
2002-12-24 |
Alexion Pharmaceuticals, Inc. |
Methods for producing transgenic pigs by microinjecting a blastomere
|
US7135333B1
(en)
|
1997-08-07 |
2006-11-14 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US6120995A
(en)
*
|
1997-08-07 |
2000-09-19 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
AU9028298A
(en)
*
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US20030175856A1
(en)
*
|
1997-08-26 |
2003-09-18 |
Genetech, Inc. |
Rtd receptor
|
DE69841176D1
(en)
*
|
1997-08-26 |
2009-11-05 |
Genentech Inc |
Rtd receptor
|
US5917124A
(en)
*
|
1997-09-12 |
1999-06-29 |
Washington University |
Transgenic mouse model of prostate cancer
|
CA2382506A1
(en)
|
1997-09-17 |
1999-03-25 |
Genentech, Inc. |
Novel polypeptides and nucleic acids encoding pro293 which are useful for treating disorders of the pancreas
|
JP4303883B2
(ja)
*
|
1997-09-18 |
2009-07-29 |
ジェネンテック・インコーポレーテッド |
DcR3ポリペプチドというTNFR相同体
|
US20040231011A1
(en)
*
|
2001-06-28 |
2004-11-18 |
Genentech, Inc. |
DcR3 polypeptide, a TNFR homolog
|
US6063359A
(en)
*
|
1997-09-26 |
2000-05-16 |
Washington University |
Method for determining oncogenic activity of a substance
|
JP2001522584A
(ja)
|
1997-10-10 |
2001-11-20 |
ジェネンテク・インコーポレイテッド |
Apo−3リガンドポリペプチド
|
WO1999019466A2
(en)
|
1997-10-14 |
1999-04-22 |
Darwin Molecular Corporation |
Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
|
US6387657B1
(en)
|
1997-10-29 |
2002-05-14 |
Genentech, Inc. |
WISP polypeptides and nucleic acids encoding same
|
US7321023B2
(en)
*
|
1997-11-07 |
2008-01-22 |
Incyte Corporation |
SP16 protein
|
ATE426036T1
(de)
*
|
1997-11-14 |
2009-04-15 |
Cedars Sinai Medical Center |
Transfektion und transfer nicht humaner mannlicher keimzellen zur generierung transgener nicht humaner saugetiere
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
DE69837897T2
(de)
|
1997-11-21 |
2008-03-06 |
Genentech Inc., San Francisco |
Mit A33 verwandte Antigene und deren pharmazeutische Verwendungen
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
JP4652566B2
(ja)
|
1998-01-12 |
2011-03-16 |
ロビン・エイ・フェルダー |
本態性高血圧症におけるgタンパク質関連変異体
|
AU2325199A
(en)
|
1998-01-15 |
1999-08-02 |
Genentech Inc. |
Apo-2 ligand
|
US6764830B1
(en)
|
1998-01-23 |
2004-07-20 |
The Regents Of The University Of California |
Thermomyces lanuginosus kinesin motor protein and methods of screening for modulators of kinesin proteins
|
AU3311699A
(en)
*
|
1998-02-25 |
1999-09-15 |
Board Of Regents Of The University And Community College System Of Nevada, The |
Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
|
US6727079B1
(en)
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
ES2389387T3
(es)
|
1998-03-17 |
2012-10-25 |
Genentech, Inc. |
Polipéptidos homólogos de VEGF y de BMP1
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
US6733991B1
(en)
*
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
DE69936382T3
(de)
|
1998-05-15 |
2011-07-07 |
Genentech, Inc., Calif. |
Therapeutische verwendungen von il-17 homologe polypeptide
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
US6548737B1
(en)
|
1998-05-15 |
2003-04-15 |
Barnes-Jewish Hospital |
Transgenic mice deficient in natural killer cells
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
ATE428441T1
(de)
|
1998-05-26 |
2009-05-15 |
Genitrix Llc |
Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
|
US6753138B1
(en)
*
|
1998-06-04 |
2004-06-22 |
Reprogen, Inc. |
Use of prothymosin in the diagnosis and treatment of endometriosis
|
AU4561199A
(en)
*
|
1998-06-12 |
1999-12-30 |
Genentech Inc. |
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
|
US20070003545A9
(en)
*
|
1999-06-02 |
2007-01-04 |
Eaton Dan L |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
US20030065154A1
(en)
*
|
2000-03-30 |
2003-04-03 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
US6976904B2
(en)
*
|
1998-07-09 |
2005-12-20 |
Li Family Holdings, Ltd. |
Chemical mechanical polishing slurry
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
EP1105160A4
(en)
*
|
1998-08-18 |
2002-02-06 |
Univ Yale |
LATS "KNOCK-OUT" ANIMAL MODELS AND THEIR USE
|
US6448078B1
(en)
|
1998-10-09 |
2002-09-10 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle
|
JP4486256B2
(ja)
*
|
1998-10-22 |
2010-06-23 |
ザ・ジェネラル・ホスピタル・コーポレイション |
副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体
|
JP2003512010A
(ja)
*
|
1998-10-28 |
2003-04-02 |
ベイラー カレッジ オブ メディスン |
卵巣特異的遺伝子およびタンパク質
|
US20020042926A1
(en)
*
|
1998-10-28 |
2002-04-11 |
Matzuk Martin M. |
Ovary-specific genes and proteins
|
US7335737B2
(en)
*
|
1998-10-28 |
2008-02-26 |
Baylor College Of Medicine |
Ovary-specific genes and proteins
|
US20060079674A1
(en)
*
|
1998-10-28 |
2006-04-13 |
Baylor College Of Medicine Wyeth |
Contraceptive targets
|
US20060205034A1
(en)
*
|
1998-10-30 |
2006-09-14 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
US20030027998A1
(en)
*
|
1998-10-30 |
2003-02-06 |
Holtzman Douglas A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
AU1409999A
(en)
*
|
1998-11-13 |
2000-06-05 |
University Of North Carolina At Chapel Hill, The |
Animal model for neurological disorders
|
NZ552959A
(en)
|
1998-11-27 |
2008-06-30 |
Darwin Discovery Ltd |
Compositions and methods for increasing bone mineralization
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
EP2075335A3
(en)
|
1998-12-22 |
2009-09-30 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
AU778759B2
(en)
|
1998-12-23 |
2004-12-16 |
Genentech Inc. |
IL-1 related polypeptides
|
AU2486800A
(en)
*
|
1998-12-31 |
2000-07-31 |
General Hospital Corporation, The |
Pth functional domain conjugate peptides, derivatives thereof and novel tetheredligand-receptor molecules
|
US7057012B1
(en)
*
|
1998-12-31 |
2006-06-06 |
The General Hospital Corporation |
PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
|
EP2357192A1
(en)
|
1999-02-26 |
2011-08-17 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
EP2301947A3
(en)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
US6531125B1
(en)
|
1999-03-02 |
2003-03-11 |
Twinstrand Therapeutics Inc. |
Antiviral ricin-like proteins
|
US7105315B2
(en)
*
|
1999-06-16 |
2006-09-12 |
Incyte Genomics, Inc. |
Transmembrane protein differentially expressed in cancer
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6864235B1
(en)
*
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
IL145775A0
(en)
|
1999-04-12 |
2002-07-25 |
Agensys Inc |
13 transmembrane protein expressed in prostate cancer
|
EP1792989A1
(en)
|
1999-04-12 |
2007-06-06 |
Agensys, Inc. |
13 Transmembrane protein expressed in prostate cancer
|
US20030131364A1
(en)
*
|
1999-04-27 |
2003-07-10 |
Karen Duff |
Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
|
CA2369747A1
(en)
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
US6974684B2
(en)
*
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040229779A1
(en)
*
|
1999-05-14 |
2004-11-18 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040023874A1
(en)
*
|
2002-03-15 |
2004-02-05 |
Burgess Catherine E. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
CA2305716A1
(en)
|
1999-05-28 |
2000-11-28 |
University Of Guelph |
Method for assay of wbpm
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
US9486429B2
(en)
*
|
1999-06-01 |
2016-11-08 |
Vanderbilt University |
Therapeutic methods employing nitric oxide precursors
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
DE60043322D1
(de)
|
1999-06-15 |
2009-12-24 |
Genentech Inc |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäuren zu deren Kodierung
|
EP1374889A1
(en)
*
|
1999-06-25 |
2004-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
JP4664554B2
(ja)
*
|
1999-07-14 |
2011-04-06 |
株式会社トランスジェニック |
トラップベクター及びこれを用いた遺伝子トラップ法
|
US6610905B1
(en)
|
1999-07-21 |
2003-08-26 |
Schering Corporation |
Transgenic mouse model for Kaposi's sarcoma
|
US6639121B1
(en)
|
1999-07-29 |
2003-10-28 |
Dana-Farber Cancer Institute, Inc. |
Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
|
ATE420175T1
(de)
|
1999-08-12 |
2009-01-15 |
Agensys Inc |
C-typ lektin transmembranantigen, das in menschlichen prostatkrebs exprimiert wird, und deren verwendungen
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
WO2001014557A1
(en)
|
1999-08-23 |
2001-03-01 |
Dana-Farber Cancer Institute, Inc. |
Pd-1, a receptor for b7-4, and uses therefor
|
NZ523206A
(en)
*
|
1999-08-31 |
2004-12-24 |
Genentech Inc |
Antibodies that bind to tumor gene sequences
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7022815B1
(en)
|
1999-09-29 |
2006-04-04 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (PTH)
|
JP4723144B2
(ja)
|
1999-09-29 |
2011-07-13 |
ザ ジェネラル ホスピタル コーポレイション |
副甲状腺ホルモン(pth)のポリペプチド誘導体
|
AU7734800A
(en)
*
|
1999-09-29 |
2001-04-30 |
General Hospital Corporation, The |
Polypeptide derivatives of parathyroid hormone (pth)
|
US6864355B1
(en)
|
2000-05-02 |
2005-03-08 |
Yale University |
Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
|
IL147952A0
(en)
|
1999-10-05 |
2002-08-14 |
Agensys Inc |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US6855806B1
(en)
*
|
1999-10-15 |
2005-02-15 |
Curagen Corporation |
Thymosin beta 10-like proteins and nucleic acids encoding same
|
US6893818B1
(en)
*
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
WO2001034646A2
(en)
|
1999-11-12 |
2001-05-17 |
Fibrogen, Inc. |
Recombinant gelatins
|
CA2491610A1
(en)
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
ATE391789T1
(de)
|
1999-12-10 |
2008-04-15 |
Invitrogen Corp |
Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
|
DK1897944T3
(da)
|
1999-12-23 |
2011-10-24 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutisk anvendelse deraf
|
EP1240350A4
(en)
|
1999-12-23 |
2003-11-19 |
Millennium Pharm Inc |
P2Y12 RECEPTOR
|
KR100828058B1
(ko)
|
2000-01-12 |
2008-05-09 |
예일 유니버시티 |
Nogo 수용체가 매개하는 축삭 성장의 차단
|
DE60137829D1
(de)
|
2000-01-13 |
2009-04-16 |
Genentech Inc |
Menschliche stra6 polypeptide
|
WO2001053323A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US20040055022A1
(en)
|
2000-02-08 |
2004-03-18 |
Nick Cheng |
Compositions and methods for screening therapeutic agents
|
JP2003527844A
(ja)
|
2000-02-11 |
2003-09-24 |
ジェネンテック・インコーポレーテッド |
血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター
|
ES2267593T3
(es)
|
2000-02-16 |
2007-03-16 |
Genentech, Inc. |
Anticuerpos anti-april y celulas hibridomas.
|
WO2001060794A2
(en)
*
|
2000-02-18 |
2001-08-23 |
The Regents Of The University Of California |
Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
|
EP1261712B1
(en)
*
|
2000-03-03 |
2006-12-13 |
Curagen Corporation |
Proteins named fctrx and nucleic acids encoding same
|
WO2001068131A1
(en)
|
2000-03-13 |
2001-09-20 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
|
US6740520B2
(en)
*
|
2000-03-21 |
2004-05-25 |
Genentech, Inc. |
Cytokine receptor and nucleic acids encoding the same
|
US20040086970A1
(en)
*
|
2000-03-22 |
2004-05-06 |
Genentech, Inc. |
Novel cytokine receptors and nucleic acids encoding the same
|
EP1265849B1
(en)
*
|
2000-03-23 |
2006-10-25 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
EP1274861B1
(en)
|
2000-03-27 |
2009-12-23 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting cancer cells
|
CA2405912A1
(en)
|
2000-04-12 |
2001-10-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20060015969A1
(en)
*
|
2000-04-28 |
2006-01-19 |
Planet Biotechnology, Inc. |
Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
|
EP1290027B1
(en)
*
|
2000-04-28 |
2009-09-09 |
Planet Biotechnology, Inc. |
Immunoadhesin for the prevention of rhinovirus infection
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US20030219786A1
(en)
*
|
2000-08-11 |
2003-11-27 |
Applied Research Systems Ars Holding N.V. |
Novel glycoproteins and methods of use thereof
|
EP1353549A2
(en)
*
|
2000-06-01 |
2003-10-22 |
PHARMACIA & UPJOHN COMPANY |
Mice heterozygous for wfs1 gene as mouse models for depression
|
EP2275549A1
(en)
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CA2648046A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
MXPA02012560A
(es)
|
2000-06-30 |
2003-05-14 |
Elan Pharm Inc |
Compuestos para tratar la enfermedad de alzheimer.
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
GB0016791D0
(en)
|
2000-07-07 |
2000-08-30 |
Novartis Ag |
Organic compounds
|
ES2323407T3
(es)
|
2000-07-12 |
2009-07-15 |
Agensys, Inc. |
Nuevo antigeno tumoral util en el diagnostico y terapia del cancer de vejiga, ovario, pulmon y riñon.
|
KR100815888B1
(ko)
*
|
2000-07-14 |
2008-03-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Hiv 보조 단백질을 암호화하는 dna 백신
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040023259A1
(en)
*
|
2000-07-26 |
2004-02-05 |
Luca Rastelli |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
AU2001284948A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
US7198924B2
(en)
*
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
ATE412009T1
(de)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
CA2420990C
(en)
|
2000-08-28 |
2010-08-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
CA2417432C
(en)
|
2000-09-01 |
2010-11-02 |
The Center For Blood Research, Inc. |
Modified polypeptides stabilized in a desired conformation and methods for producing same
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
US20030176344A1
(en)
*
|
2000-09-14 |
2003-09-18 |
Decode Genetics Ehf. |
Human osteoporosis gene
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
AU2001292728A1
(en)
*
|
2000-09-18 |
2002-03-26 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting stomach and esophageal cancer cells
|
PT1322752E
(pt)
*
|
2000-09-28 |
2010-05-06 |
Bioriginal Food & Science Corp |
Fad4, fad5, fad5-2 e fad6, novos membros da família de dessaturases de ácidos gordos e susas utilizações
|
WO2002044419A2
(en)
|
2000-11-28 |
2002-06-06 |
Wyeth |
Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
CA2429722A1
(en)
|
2000-11-28 |
2002-06-06 |
Wyeth |
Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
AU2002246758A1
(en)
*
|
2000-12-29 |
2002-07-16 |
Vanderbilt University |
Epididymal lipocalin gene and uses thereof
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040043928A1
(en)
*
|
2001-08-02 |
2004-03-04 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20030051266A1
(en)
*
|
2001-02-14 |
2003-03-13 |
Serafini Tito Andrew |
Collections of transgenic animal lines (living library)
|
EP1764734A1
(en)
*
|
2001-02-22 |
2007-03-21 |
Sony Corporation |
Content providing/obtaining system
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
WO2002075317A2
(en)
*
|
2001-03-15 |
2002-09-26 |
Novartis Ag |
Screening for drugs against disorders associated with schizophrenia
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
*
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US20090081199A1
(en)
*
|
2001-03-20 |
2009-03-26 |
Bioxell S.P.A. |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2441594A1
(en)
*
|
2001-03-22 |
2002-10-03 |
Scentgene Pollination Ltd. |
Method of enhancing entomophilous
|
CA2440676A1
(en)
|
2001-03-22 |
2002-10-03 |
Abbott Gmbh & Co. Kg |
Transgenic animals expressing antibodies specific for genes of interest and uses thereof
|
EP2388590A1
(en)
|
2001-04-02 |
2011-11-23 |
Dana Farber Cancer Institute |
PD-1, a receptor for B7-4, and uses thereof
|
US20030148298A1
(en)
*
|
2001-04-03 |
2003-08-07 |
O''toole Margot |
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
EP2278013A1
(en)
|
2001-04-16 |
2011-01-26 |
Wyeth Holdings Corporation |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
JP4384855B2
(ja)
|
2001-04-30 |
2009-12-16 |
スウィッチ・バイオテック・アクチェンゲゼルシャフト |
糖尿病随伴性および/または動脈性難治創傷の治療および/または予防のための、そして薬理学的に活性な物質を同定するための、アルファ1−アンチキモトリプシンポリペプチド類またはそれらをコード化している核酸の使用、または、actポリペプチドまたはそれをコード化している核酸を、発現している細胞の使用。
|
DE10121255A1
(de)
*
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
|
US20030017159A1
(en)
*
|
2001-05-02 |
2003-01-23 |
Jerome Ritz |
Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
|
US8216585B2
(en)
|
2001-05-25 |
2012-07-10 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
ATE483976T1
(de)
|
2001-06-05 |
2010-10-15 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
PL370139A1
(en)
*
|
2001-06-07 |
2005-05-16 |
Wyeth |
A g-protein coupled receptor and uses therefor
|
EP2322628B1
(en)
|
2001-06-14 |
2017-03-15 |
The Regents of The University of California |
Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
|
WO2002102830A1
(en)
|
2001-06-15 |
2002-12-27 |
New Century Pharmaceuticals, Inc. |
Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
|
KR100788092B1
(ko)
|
2001-06-20 |
2007-12-21 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US20030013081A1
(en)
|
2001-06-26 |
2003-01-16 |
Olson William C. |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
|
WO2003002122A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
|
US20030087274A1
(en)
*
|
2001-07-05 |
2003-05-08 |
Anderson David W. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040029790A1
(en)
*
|
2001-07-05 |
2004-02-12 |
Meera Patturajan |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20030129613A1
(en)
*
|
2001-07-05 |
2003-07-10 |
Fernandes Elma R. |
Novel human proteins and polynucleotides encoding them
|
AU2002339843B2
(en)
*
|
2001-07-23 |
2007-12-06 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (PTH) analogs
|
US6867189B2
(en)
*
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
US20030027258A1
(en)
*
|
2001-08-02 |
2003-02-06 |
Chang Fang-Tseh Frank |
Methods and compositions for pearl oyster cultivation
|
US20040030096A1
(en)
*
|
2001-08-02 |
2004-02-12 |
Linda Gorman |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20030119771A1
(en)
*
|
2001-08-22 |
2003-06-26 |
Rompaey Luc Van |
Modulators of bone homeostasis identified in a high-throughput screen
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
DE60238143D1
(de)
|
2001-09-18 |
2010-12-09 |
Genentech Inc |
Zusammensetzungen und verfahren für die diagnose von tumoren
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
US20030199442A1
(en)
*
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20070118934A1
(en)
*
|
2001-10-26 |
2007-05-24 |
Planet Biotechnology, Inc. |
Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
|
US7402406B2
(en)
|
2001-10-31 |
2008-07-22 |
Astellas Pharma Inc. |
Methods of evaluating phosphatase inhibitors
|
US7091006B2
(en)
|
2001-11-09 |
2006-08-15 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, a novel PGC-1 homologue and uses therefor
|
AU2002358947A1
(en)
*
|
2001-12-05 |
2003-06-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
AU2002359666A1
(en)
|
2001-12-10 |
2003-06-23 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
AU2002364169A1
(en)
*
|
2001-12-14 |
2003-06-30 |
President And Fellows Of Harvard College |
Dual inhibition of sister chromatide separation at metaphase
|
DE60234713D1
(de)
*
|
2001-12-18 |
2010-01-21 |
Endocube Sas |
Neue mit dem zelltod assoziierte proteine aus der thap familie und par4 verwandte signalwege, die bei der kontrolle von apoptosis involviert sind
|
US7858297B2
(en)
*
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
ES2545090T3
(es)
|
2001-12-21 |
2015-09-08 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina y GCSF
|
MXPA04006554A
(es)
|
2002-01-02 |
2005-03-31 |
Genentech Inc |
Composiciones y metodos para diagnostico y tratamiento de tumor.
|
CA2485064A1
(en)
|
2002-02-07 |
2003-08-14 |
Delta Biotechnology Limited |
Albumin-fused kunitz domain peptides
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
JP2005535290A
(ja)
|
2002-02-22 |
2005-11-24 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための組成物と方法
|
SI1485477T1
(sl)
|
2002-02-25 |
2009-10-31 |
Genentech Inc |
Novi citokinski receptor GLM-R tipa 1
|
DE60325519D1
(de)
*
|
2002-03-01 |
2009-02-12 |
Hoffmann La Roche |
Doppel-transgenisches, nicht-humanes Säugertiermodell für die Alzheimer Krankheit
|
US7153685B2
(en)
*
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
EP2011886A3
(en)
|
2002-04-16 |
2009-02-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP1499182B1
(en)
*
|
2002-04-29 |
2009-10-28 |
Thomas Jefferson University |
Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
WO2003103725A1
(en)
*
|
2002-06-07 |
2003-12-18 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2801616A1
(en)
|
2002-06-17 |
2014-11-12 |
Thrasos Innovation, Inc. |
Single domain TDF-related compounds and analogs thereof
|
US20040005571A1
(en)
*
|
2002-07-03 |
2004-01-08 |
Hawley R. Scott |
Axs gene and protein and methods related thereto
|
WO2004004649A2
(en)
|
2002-07-08 |
2004-01-15 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
US7250551B2
(en)
*
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
AU2003261366A1
(en)
*
|
2002-08-05 |
2004-02-23 |
The Wistar Institute |
Methods for regulating brca1-brca2-containing complex activity
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
CA2497304A1
(en)
*
|
2002-08-16 |
2004-02-26 |
Wyeth |
Bmp-2 estrogen responsive element and methods of using the same
|
CN101044247B
(zh)
|
2002-08-20 |
2011-06-22 |
千年药品公司 |
用于鉴定,评估,预防和治疗子宫颈癌的组合物,试剂盒及方法
|
US7135324B2
(en)
*
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
WO2004024072A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
WO2004024068A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
JP2006515165A
(ja)
|
2002-09-16 |
2006-05-25 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための新規組成物と方法
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
WO2004029212A2
(en)
|
2002-09-25 |
2004-04-08 |
University Of Massachusetts |
In vivo gene silencing by chemically modified and stable sirna
|
KR20050046751A
(ko)
*
|
2002-09-27 |
2005-05-18 |
오리디스 비오메드 포르슝스-운트 엔트비크룽스 게엠베하 |
폴리펩티드 및 이들을 암호화하는 핵산 및 간질환 및 상피세포암을 예방, 진단 또는 치료하기 위한 이들의 용도
|
BR0315327A
(pt)
*
|
2002-10-14 |
2005-08-16 |
Hoffmann La Roche |
Antagonistas de il-15
|
US20080293750A1
(en)
*
|
2002-10-17 |
2008-11-27 |
Anna Helgadottir |
Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
|
KR20050056250A
(ko)
|
2002-10-18 |
2005-06-14 |
주식회사 엘지생명과학 |
암 관련 유전자 군
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
EP1560597A4
(en)
*
|
2002-10-29 |
2007-06-27 |
Pharmacia Corp |
DIFFERENTIALLY EXPRESSED GENES INVOLVED IN CANCER, POLYPEPTIDES CODED THEREWITH, AND METHODS OF USING GENES
|
JP2006517785A
(ja)
|
2002-10-29 |
2006-08-03 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための新規組成物と方法
|
WO2004042363A2
(en)
*
|
2002-11-04 |
2004-05-21 |
Dana-Farber Cancer Institute, Inc. |
In vivo imaging of e2f-regulated bioluminescent proteins
|
AU2003295401B2
(en)
|
2002-11-08 |
2010-04-29 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP1572730A4
(en)
*
|
2002-11-22 |
2006-04-19 |
Med College Georgia Res Inst |
NACT USED AS TARGET FOR EXTENDING LIFETIME AND WEIGHT REDUCTION
|
WO2004047728A2
(en)
|
2002-11-26 |
2004-06-10 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2004050674A2
(en)
*
|
2002-12-04 |
2004-06-17 |
Algos Therapeutics, Inc. |
Methods and materials for modulating trpm2
|
WO2004056868A2
(en)
*
|
2002-12-19 |
2004-07-08 |
Endocube Sas |
Nf-hev compositions and methods of use
|
AU2003299818A1
(en)
|
2002-12-20 |
2004-07-22 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
US20040194156A1
(en)
*
|
2002-12-27 |
2004-09-30 |
Califa Llc |
Transgenic aquatic invertebrates as a bioreactor for production of recombinant polypeptides
|
AU2003292681A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Chugai Seiyaku Kabushiki Kaisha |
Wt1 transgenic animal
|
WO2004072263A2
(en)
|
2003-02-10 |
2004-08-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
EP2201960A1
(en)
*
|
2003-03-19 |
2010-06-30 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormones with alpha-helix stabilizers
|
US20040241657A1
(en)
*
|
2003-05-28 |
2004-12-02 |
Perlegen Sciences, Inc. |
Liver related disease compositions and methods
|
US20050069918A1
(en)
|
2003-05-29 |
2005-03-31 |
Francois Claret |
JAB1 as a prognostic marker and a therapeutic target for human cancer
|
NZ578591A
(en)
|
2003-05-30 |
2011-01-28 |
Agensys Inc |
Prostate stem cell antigen (PSCA) variants and subsequences thereof, namely SEQ ID NO: 6554
|
US7514593B2
(en)
*
|
2003-05-30 |
2009-04-07 |
The University Of North Carolina At Chapel Hill |
Animal model for chronic obstructive pulmonary disease and cystic fibrosis
|
US7097993B2
(en)
*
|
2003-06-25 |
2006-08-29 |
Wisconsin Alumni Research Foundation |
Method for identifying an agent that modulates type 1 phosphatidylinositol phosphate kinase isoform β661 activity
|
KR100945327B1
(ko)
|
2003-07-08 |
2010-03-08 |
제넨테크, 인크. |
Il-17a/f 이종 폴리펩티드 및 그의 치료 용도
|
US7910544B2
(en)
|
2003-07-17 |
2011-03-22 |
The General Hospital Corporation |
Conformationally constrained parthyroid hormone (PTH) analogs
|
WO2005010039A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Pfizer Products Inc. |
Bsep polypeptide variants and uses thereof
|
US20050069929A1
(en)
|
2003-08-08 |
2005-03-31 |
Invitrogen Corporation |
Methods and compositions for seamless cloning of nucleic acid molecules
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20080050313A1
(en)
|
2003-08-14 |
2008-02-28 |
Exelixis, Inc. |
Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use
|
US7354734B2
(en)
*
|
2003-08-25 |
2008-04-08 |
Funzyme Biotechnologies Sa |
Fungal proteins and nucleic acids encoding same
|
EP1670924A1
(en)
*
|
2003-08-28 |
2006-06-21 |
Aveo Pharmaceuticals, Inc. |
Tumor-specific expression of reporter genes
|
DK2380985T3
(en)
*
|
2003-09-23 |
2014-03-17 |
Univ North Carolina |
Cells expressing the vitamin K epoxide reductase, as well as their use
|
KR20060120652A
(ko)
|
2003-10-07 |
2006-11-27 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
난소암의 확인, 평가, 예방 및 치료를 위한 핵산 분자 및단백질
|
US20070274988A1
(en)
*
|
2003-10-10 |
2007-11-29 |
Five Prime Therapeautics, Inc. |
Kiaa0779, Splice Variants Thereof, and Methods of Their Use
|
DE602004026897D1
(de)
*
|
2003-10-14 |
2010-06-10 |
Baxter Healthcare Sa |
Vkorc1 (vitamin k epoxide recycling polypeptide), ein therapeutisches ziel für coumarin und deren derivate
|
EP1681988B1
(en)
|
2003-11-12 |
2015-04-08 |
The Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
EP2412725A3
(en)
|
2003-11-17 |
2012-04-25 |
Genentech, Inc. |
Antibodies against CD79b for the treatment of tumor of hematopoeitic origin
|
US20050120397A1
(en)
*
|
2003-11-24 |
2005-06-02 |
Hermann Steller |
Compounds and methods for regulation of spermatid differentiation
|
EP2405023B1
(en)
|
2003-11-26 |
2014-01-08 |
Celera Corporation |
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
|
EP1697534B1
(en)
|
2003-12-01 |
2010-06-02 |
Life Technologies Corporation |
Nucleic acid molecules containing recombination sites and methods of using the same
|
ES2380022T3
(es)
*
|
2003-12-03 |
2012-05-07 |
Monika KRÖZ |
Proteínas de fusión a interleucina-11
|
US7371539B2
(en)
*
|
2003-12-03 |
2008-05-13 |
President And Fellows Of Harvard College |
Targeted polypeptide degradation
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
JP2007518422A
(ja)
|
2004-01-21 |
2007-07-12 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
変異体ナトリウムチャンネルNaν1.7およびそれに関連する方法
|
US20100216863A1
(en)
*
|
2004-01-30 |
2010-08-26 |
Decode Genetics Ehf. |
Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
|
US8158362B2
(en)
*
|
2005-03-30 |
2012-04-17 |
Decode Genetics Ehf. |
Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
|
US20050272678A1
(en)
*
|
2004-02-11 |
2005-12-08 |
Bodine Peter Van N |
BMP-6 estrogen responsive element and methods of use thereof
|
EP3611273A1
(en)
|
2004-03-31 |
2020-02-19 |
The General Hospital Corporation |
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
|
WO2005114217A2
(en)
*
|
2004-04-20 |
2005-12-01 |
Medical College Of Georgia Research Institute, Inc. |
Na+ and ci> coupled transport system for endogenous opioid peptides
|
EP2423327B1
(en)
|
2004-05-07 |
2014-01-08 |
Celera Corporation |
Genetic polymorphism associated with liver fibrosis methods of detection and uses thereof
|
US20060014934A1
(en)
*
|
2004-05-18 |
2006-01-19 |
Everse Stephen J |
Crystal structure of factor Vai and method for identifying blood factor Va modulators
|
CN103356636A
(zh)
|
2004-05-23 |
2013-10-23 |
杰勒德·M·豪斯 |
Theramutein调节剂
|
NZ551627A
(en)
|
2004-05-28 |
2010-02-26 |
Agensys Inc |
Antibodies and related molecules that bind to PSCA proteins
|
EP1766017B1
(en)
|
2004-06-10 |
2015-01-21 |
Viventia Bio Inc. |
Tumor specific antibody
|
CA2571218C
(en)
|
2004-06-17 |
2015-11-03 |
William D. Carlson |
Tdf-related compounds and analogs thereof
|
US7288385B2
(en)
|
2004-06-25 |
2007-10-30 |
The Salk Institute For Biological Studies |
Increasing life span by modulation of Smek
|
US7968762B2
(en)
|
2004-07-13 |
2011-06-28 |
Van Andel Research Institute |
Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
|
EP2287310B1
(en)
|
2004-07-22 |
2015-05-06 |
Five Prime Therapeutics, Inc. |
Compositions and methods using MGD-CSF in disease treatment
|
WO2007001324A2
(en)
|
2004-07-23 |
2007-01-04 |
The University Of North Carolina At Chapel Hill |
Methods and materials for determining pain sensitivity and predicting and treating related disorders
|
EP1789437A4
(en)
*
|
2004-07-30 |
2008-11-05 |
Sinai School Medicine |
INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF
|
DE102004037860A1
(de)
*
|
2004-08-04 |
2006-03-16 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
|
US20060031945A1
(en)
*
|
2004-08-06 |
2006-02-09 |
Yu Shen |
Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
|
WO2006021896A2
(en)
|
2004-08-27 |
2006-03-02 |
Tripep Ab |
Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics
|
WO2006055836A2
(en)
*
|
2004-11-16 |
2006-05-26 |
President And Fellows Of Harvard College |
In vivo alteration of cellular dna
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP1839120B1
(en)
|
2004-12-21 |
2013-10-23 |
Janssen Biotech, Inc. |
Anti-il-12 antibody based vectors, host cells, and methods of production and uses
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
US7850960B2
(en)
|
2004-12-30 |
2010-12-14 |
University Of Washington |
Methods for regulation of stem cells
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
EP1856296A2
(en)
|
2005-03-11 |
2007-11-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
US20090325226A1
(en)
|
2005-03-15 |
2009-12-31 |
Stafford Darrel W |
Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
|
EP2444099A1
(en)
|
2005-03-31 |
2012-04-25 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161P2F10B proteins
|
US20070061899A1
(en)
*
|
2005-04-13 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Transgenic mammal with constitutive, tissue-specific cytokine expression and use as a cancer model
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
US8431110B2
(en)
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
JP2008541781A
(ja)
|
2005-06-06 |
2008-11-27 |
ジェネンテック・インコーポレーテッド |
異なる遺伝子に対するトランスジェニック動物、および遺伝子の特徴づけのためのその使用
|
US8945857B2
(en)
|
2005-07-01 |
2015-02-03 |
John Schrader |
Methods of isolating cells and generating monoclonal antibodies
|
CN101437539B
(zh)
*
|
2005-07-05 |
2013-10-02 |
康奈尔研究基金会(有限公司) |
通过干扰cd99l2阻断白细胞迁出和炎症
|
ES2336832T3
(es)
|
2005-07-22 |
2010-04-16 |
Five Prime Therapeutics, Inc. |
Composiciones y procedimientos para tratar enfermedades con proteinas de fusion de fgfr.
|
AU2006292827B2
(en)
|
2005-08-09 |
2013-02-14 |
Revivicor, Inc. |
Transgenic ungulates expressing CTLA4-IG and uses thereof
|
JP2009504183A
(ja)
|
2005-08-15 |
2009-02-05 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、それに関連する組成物および方法
|
EP1931384A4
(en)
|
2005-09-09 |
2010-03-10 |
Univ Johns Hopkins |
MANIPULATION OF THE REGULATORY T CELL AND DC FUNCTION BY TARGETING THE NEURITINE GENE WITH ANTIBODIES, AGONISTS AND ANTAGONISTS
|
EP1926459B1
(en)
|
2005-09-19 |
2015-01-07 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
DK2497780T3
(en)
|
2005-09-20 |
2015-06-01 |
Thrasos Innovation Inc |
TDF-related compounds and analogs thereof
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
DE102005048898A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
EP1951906B1
(en)
*
|
2005-11-10 |
2010-12-22 |
Bristol-Myers Squibb Pharma Company |
Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
|
CA2630432A1
(en)
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
US20090275070A1
(en)
*
|
2005-11-23 |
2009-11-05 |
Housey Gerard M |
Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators
|
US20090253585A1
(en)
*
|
2005-11-30 |
2009-10-08 |
Luda Diatchenko |
Identification of Genetic Polymorphic Variants Associated With Somatosensory Disorders and Methods of Using the Same
|
JP5236488B2
(ja)
|
2005-12-14 |
2013-07-17 |
ハーモ ファーマ エルテーデー. |
新規な神経栄養因子タンパク質およびその用途
|
JP2009520469A
(ja)
*
|
2005-12-22 |
2009-05-28 |
コンジュクヘム ビオテクフノロギエス インコーポレイテッド |
アルブミンと治療薬との前もって形成された抱合体の産生のための方法
|
ES2403206T3
(es)
|
2005-12-23 |
2013-05-16 |
Ariad Pharmaceuticals, Inc. |
Compuestos bicíclicos de heteroarilo
|
JP2009525110A
(ja)
|
2006-01-31 |
2009-07-09 |
マルチ ジーン バスキュラー システムズ, インコーポレイテッド |
薬物溶出血管内プロテーゼおよび使用方法
|
WO2007092777A2
(en)
*
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
EP1993548A2
(en)
*
|
2006-03-01 |
2008-11-26 |
Roskamp Research LLC |
Compounds for inhibiting beta-amyloid production
|
US20070250941A1
(en)
*
|
2006-03-27 |
2007-10-25 |
Genentech, Inc. |
VEGF Receptor Conditional Knockout Animals and Methods of Use
|
US20090288176A1
(en)
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
US20070256148A1
(en)
*
|
2006-04-26 |
2007-11-01 |
Katz David A |
DEP2 and its uses in major depressive disorder and other related disorders
|
US8933209B2
(en)
|
2006-04-26 |
2015-01-13 |
Abbvie Inc. |
Dep2 and its uses in major depressive disorder and other related disorders
|
WO2007133797A2
(en)
|
2006-05-15 |
2007-11-22 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
EP2035439A4
(en)
|
2006-06-05 |
2010-01-13 |
Cancer Care Ontario |
RISK ASSESSMENT FOR COLORECTAL CANCER
|
EP1873527A1
(en)
*
|
2006-06-30 |
2008-01-02 |
Schwarz Pharma Ag |
Method for identifying CRMP modulators
|
CN101466390B
(zh)
*
|
2006-06-15 |
2014-03-12 |
优时比制药有限公司 |
用于治疗难治性癫痫持续状态的肽类化合物
|
US8124831B2
(en)
*
|
2006-07-06 |
2012-02-28 |
Duke University |
Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
|
US8143374B2
(en)
*
|
2006-08-04 |
2012-03-27 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (PTH)
|
US9505823B2
(en)
*
|
2006-08-07 |
2016-11-29 |
TEV A Biopharmaceuticals USA, Inc. |
Albumin-insulin fusion proteins
|
US20100316626A1
(en)
*
|
2006-08-11 |
2010-12-16 |
The Government Of The United States Of America As Represented By The Secretary |
Methods for treatment and diagnosis of psychiatric disorders
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
US7993833B2
(en)
|
2006-09-11 |
2011-08-09 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
EP2061515A4
(en)
|
2006-09-14 |
2013-01-30 |
Medgenics Medical Israel Ltd |
LONG-TERM MEDICINAL FORMULATIONS
|
US8454948B2
(en)
|
2006-09-14 |
2013-06-04 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
WO2008094316A2
(en)
*
|
2006-09-22 |
2008-08-07 |
Stowers Institute Of Medical Research |
Novel branchiostoma derived fluorescent proteins
|
WO2008051511A2
(en)
|
2006-10-20 |
2008-05-02 |
Applera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
US9018440B2
(en)
*
|
2006-10-27 |
2015-04-28 |
Stowers Institute For Medical Research |
Fluorescent mouse model
|
EP2120557A4
(en)
*
|
2006-12-08 |
2010-02-10 |
Roskamp Res Llc |
POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
CA2679954A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008152507A2
(en)
|
2007-03-16 |
2008-12-18 |
Multigene Vascular Systems, Inc. |
Compositions and methods for treating ophthalmic disorders
|
EP1975228A1
(en)
|
2007-03-28 |
2008-10-01 |
Fachhochschule Mannheim |
Polynucleotides for enhancing expression of a polynucleotide of interest
|
EP2144935A2
(en)
|
2007-03-29 |
2010-01-20 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
US20100077496A1
(en)
*
|
2007-04-20 |
2010-03-25 |
Mt. Sinai School Of Medicine |
MO-1, A Gene Associated With Morbid Obesity
|
CA2687787A1
(en)
*
|
2007-05-21 |
2008-12-18 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for cancer gene discovery
|
KR101572700B1
(ko)
|
2007-06-07 |
2015-11-30 |
제넨테크, 인크. |
보체-관련 장애의 예방 및 치료를 위한 C3b 항체 및 방법
|
EP2006376A1
(en)
*
|
2007-06-21 |
2008-12-24 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
|
JP5711966B2
(ja)
|
2007-08-01 |
2015-05-07 |
ザ ジェネラル ホスピタル コーポレイション |
Gタンパク質共役受容体および関連組成物を使用するスクリーニング方法
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
CA2704973A1
(en)
|
2007-11-08 |
2009-05-14 |
Genentech, Inc. |
Anti-factor b antibodies and their uses
|
NZ586053A
(en)
|
2007-11-09 |
2012-09-28 |
Peregrine Pharmaceuticals Inc |
Anti-vegf antibody compositions and methods
|
US20090235369A1
(en)
*
|
2007-12-31 |
2009-09-17 |
Baxter Healthcare S.A. |
Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
|
JP5623916B2
(ja)
*
|
2008-01-31 |
2014-11-12 |
バンダービルト・ユニバーシティVanderbilt University |
動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
|
TR201903753T4
(tr)
*
|
2008-01-31 |
2019-03-21 |
Univ Vanderbilt |
Akciğer rahatsızlıkları için terapötik tedavi.
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
US8288094B2
(en)
*
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
HUE036780T2
(hu)
|
2008-04-09 |
2018-07-30 |
Genentech Inc |
Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
AU2009248923B2
(en)
|
2008-05-21 |
2015-01-29 |
Takeda Pharmaceutical Company Limited |
Phosphorous derivatives as kinase inhibitors
|
US8216786B2
(en)
|
2008-07-09 |
2012-07-10 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
US8709758B2
(en)
*
|
2008-07-28 |
2014-04-29 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for inhibition of neutrophil exocytosis
|
US8241846B1
(en)
|
2008-09-08 |
2012-08-14 |
Institut De Recherches Cliniques De Montreal |
Hedgehog pathway modulation and uses thereof for treating, preventing and/or diagnosing cancer
|
US20110206736A1
(en)
*
|
2008-09-23 |
2011-08-25 |
Thomas Jefferson University |
Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
|
CA2739192A1
(en)
|
2008-10-01 |
2010-04-08 |
Tet Systems Gmbh & Co.Kg |
Tetracycline inducible transcription control sequence
|
WO2010062604A2
(en)
*
|
2008-10-27 |
2010-06-03 |
Baxter International Inc. |
Models of thrombotic thrombocytopenic purpura and methods of use thereof
|
WO2010056311A1
(en)
|
2008-11-12 |
2010-05-20 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
WO2010071836A1
(en)
|
2008-12-19 |
2010-06-24 |
Inserm |
Il-15 mediated nk and t cell maturation
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
US8653080B2
(en)
|
2009-01-14 |
2014-02-18 |
Salk Institute For Biological Studies |
Methods for screening and compounds that protect against amyloid diseases
|
US8008539B1
(en)
|
2009-03-19 |
2011-08-30 |
University Of South Florida |
Generation of transgenic human soluble amyloid precursor protein alpha expressing mice
|
DK2414523T3
(da)
|
2009-04-03 |
2020-08-31 |
Inst Nat Sante Rech Med |
Mus med dendtritcelle-forstærket humaniseret immunsystem
|
US8722964B2
(en)
*
|
2009-04-23 |
2014-05-13 |
Transposagen Biopharmaceuticals, Inc. |
Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
|
WO2010147803A2
(en)
|
2009-06-08 |
2010-12-23 |
Regents Of The University Of Michigan |
Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
|
GB0909906D0
(en)
|
2009-06-09 |
2009-07-22 |
Affitech As |
Antibodies
|
GB0909904D0
(en)
|
2009-06-09 |
2009-07-22 |
Affitech As |
Product
|
EP2261242A1
(en)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartate-N-acetyltransferase enzyme, diagnostic method and therapeutic method
|
WO2011002988A1
(en)
|
2009-07-01 |
2011-01-06 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (scid)
|
EP2456876A2
(en)
|
2009-07-24 |
2012-05-30 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
US20110072524A1
(en)
*
|
2009-08-04 |
2011-03-24 |
Baxter International Inc. |
Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A
|
WO2011017518A2
(en)
|
2009-08-05 |
2011-02-10 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for drug metabolism
|
EP2467013A2
(en)
|
2009-08-20 |
2012-06-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
JP5874881B2
(ja)
|
2009-10-06 |
2016-03-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
遺伝子改変されたマウスおよび移植方法
|
EP2491116A4
(en)
|
2009-10-22 |
2013-12-11 |
Univ Jefferson |
CELL-BASED ANTI-RISK COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
|
RU2539772C2
(ru)
|
2009-10-22 |
2015-01-27 |
Дженентек, Инк. |
Способы и композиции для модуляции гепсином стимулирующего макрофаги белка
|
US20110165648A1
(en)
|
2009-11-04 |
2011-07-07 |
Menno Van Lookeren Campagne |
Co-crystal structure of factor D and anti-factor D antibody
|
CA2780221A1
(en)
|
2009-11-04 |
2011-05-12 |
Fabrus Llc |
Methods for affinity maturation-based antibody optimization
|
CN103755809B
(zh)
|
2009-11-30 |
2016-06-01 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
WO2011082187A1
(en)
|
2009-12-30 |
2011-07-07 |
Genentech, Inc. |
Methods for modulating a pdgf-aa mediated biological response
|
US10429384B2
(en)
|
2010-01-22 |
2019-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
GB201002238D0
(en)
|
2010-02-10 |
2010-03-31 |
Affitech As |
Antibodies
|
AR080243A1
(es)
|
2010-02-23 |
2012-03-21 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CA3079122A1
(en)
|
2010-03-26 |
2011-09-29 |
Trustees Of Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
CA3007805C
(en)
|
2010-04-29 |
2019-11-26 |
The Regents Of The University Of California |
Pathway recognition algorithm using data integration on genomic models (paradigm)
|
SG185027A1
(en)
|
2010-05-03 |
2012-11-29 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
KR101900078B1
(ko)
|
2010-05-13 |
2018-09-18 |
더 제너럴 하스피탈 코포레이션 |
부갑상선 호르몬 아날로그 및 그의 용도
|
KR102042253B1
(ko)
|
2010-05-25 |
2019-11-07 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Bambam:고처리율 서열분석 데이터의 병렬 비교 분석
|
US9646134B2
(en)
|
2010-05-25 |
2017-05-09 |
The Regents Of The University Of California |
Bambam: parallel comparative analysis of high-throughput sequencing data
|
WO2011159758A2
(en)
|
2010-06-15 |
2011-12-22 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
GB201020738D0
(en)
|
2010-12-07 |
2011-01-19 |
Affitech Res As |
Antibodies
|
WO2012088222A2
(en)
|
2010-12-21 |
2012-06-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
AU2012217792A1
(en)
|
2011-02-14 |
2013-08-29 |
Revivicor, Inc. |
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
|
MY162984A
(en)
|
2011-02-15 |
2017-07-31 |
Regeneron Pharma |
Humanized m-csf mice
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
EP2726103B1
(en)
|
2011-07-01 |
2018-09-05 |
The Trustees Of The University Of Pennsylvania |
Anti-properdin antibodies and uses thereof
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun (Shanghai)Science & Technology Limited |
Compositions and methods for treating heart failure
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
EP3196214B1
(en)
|
2012-02-15 |
2019-07-31 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
WO2013133708A1
(en)
|
2012-03-07 |
2013-09-12 |
Stichting Vu-Vumc |
Compositions and methods for diagnosing and treating intellectual disability syndrome, autism and autism related disorders
|
US9540657B2
(en)
|
2012-05-25 |
2017-01-10 |
California Institute Of Technology |
Expression of secreted and cell-surface polypeptides
|
WO2013192504A1
(en)
|
2012-06-22 |
2013-12-27 |
The Trustees Of Dartmouth College |
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
US9265238B2
(en)
|
2012-08-31 |
2016-02-23 |
Lisa Porter |
MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models
|
US10251379B2
(en)
|
2012-08-31 |
2019-04-09 |
University Of Windsor |
MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models
|
US9185890B2
(en)
|
2012-08-31 |
2015-11-17 |
Lisa Porter |
MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models
|
JP6368308B2
(ja)
|
2012-09-07 |
2018-08-01 |
トラスティーズ・オブ・ダートマス・カレッジ |
癌の診断および治療のためのvista調節剤
|
JP6283031B2
(ja)
|
2012-09-07 |
2018-02-21 |
イエール ユニバーシティ |
遺伝学的に修飾された非ヒト動物およびその使用法
|
CA2887706C
(en)
|
2012-11-05 |
2022-08-02 |
Regeneron Pharmaceuticals |
Genetically modified non-human animals and methods of use thereof
|
SG10201808523RA
(en)
|
2013-03-15 |
2018-11-29 |
Genentech Inc |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
WO2014191630A2
(en)
|
2013-05-28 |
2014-12-04 |
Helsingin Yliopisto |
Non-human animal model encoding a non-functional manf gene
|
ES2761280T3
(es)
|
2013-09-12 |
2020-05-19 |
Icahn School Med Mount Sinai |
Métodos de producción de animales transgénicos con receptores de células T que son específicos de una proteína fluorescente
|
EP3060144A1
(en)
|
2013-10-24 |
2016-08-31 |
Medgenics Medical Israel, Ltd |
Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof
|
SI3712174T1
(sl)
|
2013-12-24 |
2022-06-30 |
Janssen Pharmaceutica Nv |
Protitelesa in delci proti VISTA
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
US20150327523A1
(en)
*
|
2014-05-13 |
2015-11-19 |
University Of South Florida |
Transgenic mouse model for conditional fkbp51 expression and related methods
|
DK3841877T3
(da)
|
2014-05-19 |
2023-11-27 |
Regeneron Pharma |
Genetisk modificeret mus, der eksprimerer human EPO
|
WO2015191881A2
(en)
|
2014-06-11 |
2015-12-17 |
Green Kathy A |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
JP6738316B2
(ja)
|
2014-07-17 |
2020-08-12 |
ノヴォ ノルディスク アクティーゼルスカブ |
粘度を低下させるためのtrem−1抗体の部位特異的変異誘発
|
RS60737B1
(sr)
|
2014-10-21 |
2020-09-30 |
Ariad Pharma Inc |
Kristalni oblici 5-hloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
FI3253406T3
(fi)
|
2015-02-05 |
2024-01-18 |
Canem Holdings Llc |
Koostumukset granulomatoottisen polyangiitin hoitamista varten
|
PT3282835T
(pt)
|
2015-04-13 |
2023-07-25 |
Univ Yale |
Ratinhos knockin de sirpa-il15 humanizadas e métodos de utilização dos mesmos
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
WO2017053433A1
(en)
|
2015-09-21 |
2017-03-30 |
Modern Meadow, Inc. |
Fiber reinforced tissue composites
|
CA3002676A1
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
US11466252B2
(en)
|
2016-01-29 |
2022-10-11 |
Massachusetts Eye And Ear Infirmary |
Expansion and differentiation of inner ear supporting cells and methods of use thereof
|
JP2019509993A
(ja)
|
2016-02-12 |
2019-04-11 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista(b7h5)抗体
|
ES2806990T3
(es)
|
2016-02-15 |
2021-02-19 |
Modern Meadow Inc |
Procedimiento para fabricar un material biofabricado que contiene fibrillas de colágeno
|
CA3020848A1
(en)
|
2016-04-15 |
2017-10-19 |
Janssen Pharmaceuticals, Inc. |
Anti-human vista antibodies and use thereof
|
CA3008850A1
(en)
|
2017-06-29 |
2018-12-29 |
Modern Meadow, Inc. |
Yeast strains and methods for producing collagen
|
AU2018253595A1
(en)
|
2017-11-13 |
2019-05-30 |
Modern Meadow, Inc. |
Biofabricated leather articles having zonal properties
|
US11155618B2
(en)
|
2018-04-02 |
2021-10-26 |
Bristol-Myers Squibb Company |
Anti-TREM-1 antibodies and uses thereof
|
MX2021008462A
(es)
|
2019-01-17 |
2021-08-19 |
Modern Meadow Inc |
Materiales de colageno estratificados y metodos para fabricarlos.
|
EP4054324A1
(en)
|
2019-11-05 |
2022-09-14 |
Versiti Blood Research Institute Foundation, Inc. |
A murine model of fetal/neonatal alloimmune thrombocytopenia
|
US11266129B2
(en)
|
2019-11-05 |
2022-03-08 |
Versiti Blood Research Institute Foundation, Inc. |
Murine model of fetal/neonatal alloimmune thrombocytopenia
|
EP4247151A1
(en)
|
2020-11-20 |
2023-09-27 |
Revivicor Inc. |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
US11566262B2
(en)
|
2021-03-24 |
2023-01-31 |
Dna Twopointo Inc. |
Tetracycline-inducible expression systems
|
WO2022235929A1
(en)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Animal model having homologous recombination of mouse pth1 receptor
|
AU2022347161A1
(en)
|
2021-09-20 |
2024-04-04 |
Revivicor, Inc. |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|